Effects of doxycycline on articular cartilage GAG release and mechanical properties following impact.
The effects of doxycycline were examined on articular cartilage glycosaminoglycan (GAG) release and biphasic mechanical properties following two levels of impact loading at 1 and 2 weeks post-injury. Further, treatment for two continuous weeks was compared to treatment for only the 1st week of a 2-week culture period. Following impact at two levels, articular cartilage explants were cultured for 1 or 2 weeks with 0, 50, or 100 microM doxycycline. Histology, GAG release to the media, and creep indentation biomechanical properties were examined. The "High" (2.8 J) impact level had gross surface damage, whereas "Low" (1.1 J) impact was indiscernible from non-impacted controls. GAG staining decreased after High impact, but doxycycline did not visibly affect staining. High impact resulted in decreased aggregate moduli at both 1 and 2 weeks and increased permeability at 2 weeks, but tissue mechanical properties were not affected by doxycycline treatment. At 1 week, High impact resulted in more GAG release compared to non-impacted controls. However, following High impact, 100 microM doxycycline reduced cumulative GAG release at 1 and 2 weeks by 30% and 38%, respectively, compared to no treatment. Interestingly, there was no difference in GAG release comparing 2 weeks continuous treatment with 1 week on, 1 week off. These results support the hypothesis that doxycycline can mitigate GAG release from articular cartilage following impact loads. However, doxycycline was unable to prevent the loss of tissue stiffness observed post-impact, presumably due to initial matrix damage resulting solely from mechanical trauma.
Blumberg
Todd J
TJ
Department of Bioengineering, Rice University, 6100 Main Street, Keck Hall Suite 116 Houston, Texas 77005, USA.
Natoli
Roman M
RM
Athanasiou
Kyriacos A
KA
D000818:Animals; D002358:Cartilage, Articular / Q000187:drug effects* / Q000293:injuries* / Q000378:metabolism; D002417:Cattle; D004318:Doxycycline / Q000494:pharmacology*; D004548:Elasticity / Q000187:drug effects; D006025:Glycosaminoglycans / Q000032:analysis / Q000378:metabolism*
D006025:Glycosaminoglycans; D004318:Doxycycline